Blackstone Labs | BSL Chosen1

Blackstone Labs Chosen1 is a single-pathway prohormone formula built around one job: delivering 1-DHEA precursors that convert downstream to 1-testosterone, a non-aromatizing androgen associated with dry lean mass support, harder muscular appearance, and performance-focused body recomposition. This is not a conventional sports nutrition product and it should not be evaluated like a pre-workout or testosterone booster. The formulation philosophy is narrow and deliberate: instead of spreading the label across herbs, amino acids, and underdosed support ingredients, Chosen1 concentrates on a 1-DHEA blend delivered in multiple forms to influence absorption and release characteristics.

The verified active complex is a 1-DHEA blend totaling 65 mg per tablet, with label instructions commonly used at 1 tablet twice daily for 130 mg daily total. The three disclosed actives are 1-androstene-3b-ol,17-one, 1-androstene-3b-ol,17-one undecanoate, and 1-androstene-3b-ol,17-one caprylate. 1-DHEA is best understood as a precursor in the 1-testosterone pathway. After ingestion and enzymatic conversion, it is designed to increase the availability of the active androgen 1-testosterone rather than testosterone itself. That distinction matters. 1-testosterone is valued in physique circles because it does not convert to estrogen through aromatase, which is why users typically pursue it for “dry” gains rather than scale weight driven by water retention.

Dose context is important. The 130 mg/day total commonly used with this product sits within the broad practical use range historically seen for 1-DHEA products, though high-quality published human data are far thinner than they are for mainstream ergogenics like creatine or citrulline. That means this is a category where mechanistic rationale and real-world use history are stronger than robust modern clinical outcome data. The inclusion of undecanoate and caprylate forms suggests an attempt to modulate lipophilicity and delivery, potentially extending availability compared with using only the parent compound. Blackstone Labs has also been associated with liposomal-style delivery claims through phosphatidylcholine and cyclodextrin excipients, but claims like “99% bioavailability” should be treated cautiously; they are marketing-forward and not the same as having direct human pharmacokinetic proof.

The synergy here is not about stacking many different performance mechanisms. It is about creating a multi-form 1-DHEA system: one core precursor, multiple delivery forms, one endocrine target. That can appeal to users who prefer focused formulas over blend-heavy labels. On transparency, this product is partially transparent. The blend total is disclosed at 65 mg per tablet, but the exact amount of each 1-DHEA form is not broken out. That is better than a fully hidden proprietary matrix, but it still prevents precise ingredient-by-ingredient evaluation.

What should you expect? Day 1 does not feel like a stimulant product because this is not one. There is no immediate “hit.” The intended experience is cumulative: over 2 to 4 weeks, users typically look for improved training drive, a denser and drier visual appearance, better strength expression, and support for lean mass progression when calories, protein, and programming are already in place. The biggest takeaway is simple: Chosen1 is a specialized 1-DHEA formula for informed users pursuing non-estrogenic physique support, not a casual entry-level supplement.

How to Use Blackstone Labs Chosen1